Data / Research funding / Mcgill University
Mcgill University: 10 NIH awards ($9.1M), fiscal years 2021 to 2026
Mcgill University in Montreal is funded under 10 NIH awards ($9.1M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- VJ62F6V2LE48UEI
Awards
10 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Bioprintable composite materials and microfluidic tools for vocal fold restoration and repair | NIH | National Institute on Deafness and Other Communication Disorders | 2021 to 2025 | $2,474,309 | January 1, 2021 | December 31, 2026 | MONGEAU, LUC | reporter.nih.gov |
| Investigating the impact of loneliness on brain aging and pre-symptomatic Alzheimer's disease progression | NIH | National Institute on Aging | 2021 to 2024 | $2,048,032 | September 15, 2020 | April 30, 2026 | SPRENG, ROBERT NATHAN | reporter.nih.gov |
| Exposure to Insecticides and Child Growth and Pubertal Development in a South African Population Exposed Through Indoor Residual Spraying | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $1,663,772 | November 22, 2019 | October 31, 2026 | CHEVRIER, JONATHAN | reporter.nih.gov |
| Amphetamine in adolescence disrupts frontal cortex development | NIH | National Institute on Drug Abuse | 2021 to 2024 | $1,035,897 | April 1, 2015 | July 31, 2025 | FLORES, CECILIA | reporter.nih.gov |
| Quantifying the Breadth and Duration of Immunity Induced by Meningococcal B Vaccines | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,021,906 | January 1, 2018 | December 31, 2024 | BASTA, NICOLE ELAINE | reporter.nih.gov |
| Large-scale screen with a novel assay against RNA editing to identify anti-trypanosomal agents | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $362,540 | March 6, 2019 | February 28, 2023 | SALAVATI, REZA SALAVATI | reporter.nih.gov |
| Continuous ketone monitoring with the use of SGLT2 inhibitors in T1D | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $194,654 | September 10, 2025 | August 31, 2028 | HAIDAR, AHMAD | reporter.nih.gov |
| Characterizing the interaction between neural attention and somato-motor systems in non-demented patients with Parkinson's disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $138,758 | December 1, 2020 | November 30, 2023 | WIESMAN, ALEX I | reporter.nih.gov |
| The behavioral and neurocognitive effects of bilingual experience on cognitive control and language processing: Implications for aging in two languages | NIH | National Institute on Aging | 2021 to 2022 | $133,576 | June 1, 2020 | May 31, 2023 | BEATTY-MARTINEZ, ANNE L | reporter.nih.gov |
| Imaging Alterations in Endocannabinoid Metabolism in Clinical High Risk and First Episode Psychosis | NIH | National Institute of Mental Health | 2022 | $1 | September 20, 2017 | June 2, 2022 | MIZRAHI, ROMINA | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 3 | $1,084,067 | 0 | $0 |
| 2024 | 4 | $1,632,147 | 0 | $0 |
| 2023 | 6 | $2,389,889 | 0 | $0 |
| 2022 | 7 | $1,829,700 | 0 | $0 |
| 2021 | 6 | $2,137,642 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) | PAR-25-095 | NIH | 93.866 | November 6, 2026 | $350,000 | Same assistance listing 93.866 as 2 awards here |
| Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed) | RFA-AG-27-010 | NIH | 93.866 | November 10, 2026 | Not listed | Same assistance listing 93.866 as 2 awards here |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 2 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 2 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 2 awards here |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) | PAR-25-096 | NIH | 93.866 | November 17, 2026 | $200,000 | Same assistance listing 93.866 as 2 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 2 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 2 awards here |
| HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) | RFA-AT-25-003 | NIH | 93.866 | November 23, 2026 | $375,000 | Same assistance listing 93.866 as 2 awards here |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | PA-23-317 | NIH | 93.866 | November 24, 2026 | Not listed | Same assistance listing 93.866 as 2 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.866 | December 3, 2026 | Not listed | Same assistance listing 93.866 as 2 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.866 | December 3, 2026 | Not listed | Same assistance listing 93.866 as 2 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.866 | December 4, 2026 | Not listed | Same assistance listing 93.866 as 2 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.866 | January 5, 2027 | Not listed | Same assistance listing 93.866 as 2 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.866 | January 5, 2027 | Not listed | Same assistance listing 93.866 as 2 awards here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.866 | January 7, 2027 | $375,000 | Same assistance listing 93.866 as 2 awards here |
| Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) | PAR-25-378 | NIH | 93.866 | January 7, 2027 | Not listed | Same assistance listing 93.866 as 2 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 2 awards here |
| HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) | RFA-NS-25-023 | NIH | 93.866 | January 15, 2027 | $350,000 | Same assistance listing 93.866 as 2 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 2 awards here |
Topics of its NIH awards
- Clinical Research
- Behavioral and Social Science
- Neurosciences
- Prevention
- Brain Disorders
- Biotechnology
- Infectious Diseases
- Rare Diseases
- Aging
- Pediatric
- Orphan Drug
- Vector-Borne Diseases
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.